NCT00002458已完成2 期
Phase II Study of Adjuvant Therapy With Antiganglioside GD2-Specific Mouse Monoclonal Antibody 3F8 for Metastatic Neuroblastoma in Second Remission
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 1
研究概览
简要总结
RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells.
PURPOSE: Phase II trial to study the effectiveness of monoclonal antibody in treating children with metastatic neuroblastoma in second remission.
详细描述
OBJECTIVES: I. Evaluate the efficacy of ganglioside GD2-specific monoclonal antibody 3F8 as adjuvant therapy in patients with Stage IV neuroblastoma in second remission.
OUTLINE: Biological Response Modifier Therapy. Antiganglioside GD2-specific Monoclonal Antibody 3F8, MOAB 3F8.
PROJECTED ACCRUAL: A maximum of 20 patients will be entered.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- — 至 18 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney CancerStage IV Renal Cell CancerRecurrent Renal Cell CancerNCT00019539National Cancer Institute (NCI)
已完成
1 期
Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone MetastasesHypercalcemia of MalignancyMetastatic CancerPainBreast CancerNCT00060138Chugai Pharmaceutical
已完成
2 期
Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced NeuroblastomaNeuroblastomaNCT00002560Memorial Sloan Kettering Cancer Center40
已完成
1 期
Monoclonal Antibody Therapy in Treating Patients With Advanced CancerChronic Myeloproliferative DisordersMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesPrecancerous/Nonmalignant ConditionUnspecified Adult Solid Tumor, Protocol SpecificLymphomaLeukemiaNCT00003082University of Arizona27
终止
1 期
Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaLymphomaNCT00033423University of Alabama at Birmingham18